USD 23.71
(-2.39%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 580.31 Million USD | 2.04% |
2022 | 568.7 Million USD | 29.06% |
2021 | 440.64 Million USD | -0.92% |
2020 | 444.75 Million USD | 152.91% |
2019 | 175.85 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 592.89 Million USD | 2.17% |
2024 Q2 | 618.2 Million USD | 4.27% |
2023 FY | 580.31 Million USD | 2.04% |
2023 Q1 | 557.88 Million USD | -1.9% |
2023 Q2 | 561.7 Million USD | 0.69% |
2023 Q4 | 580.31 Million USD | 0.95% |
2023 Q3 | 574.87 Million USD | 2.34% |
2022 Q1 | 544.66 Million USD | 23.61% |
2022 FY | 568.7 Million USD | 29.06% |
2022 Q4 | 568.7 Million USD | 3.37% |
2022 Q3 | 550.15 Million USD | 1.21% |
2022 Q2 | 543.55 Million USD | -0.2% |
2021 Q3 | 459.56 Million USD | 11.64% |
2021 Q2 | 411.63 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2021 Q4 | 440.64 Million USD | -4.12% |
2021 FY | 440.64 Million USD | -0.92% |
2020 FY | 444.75 Million USD | 152.91% |
2020 Q4 | 444.75 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 FY | 175.85 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Alcon Inc. | 29.6 Billion USD | 98.04% |
AptarGroup, Inc. | 4.45 Billion USD | 86.965% |
Baxter International Inc. | 28.27 Billion USD | 97.948% |
Becton, Dickinson and Company | 52.78 Billion USD | 98.901% |
Bausch + Lomb Corporation | 13.44 Billion USD | 95.683% |
Haemonetics Corporation | 2.19 Billion USD | 73.569% |
Envista Holdings Corp | 6.6 Billion USD | 91.214% |
ResMed Inc. | 6.87 Billion USD | 91.556% |
Teleflex Incorporated | 7.53 Billion USD | 92.296% |
West Pharmaceutical Services, Inc. | 3.82 Billion USD | 84.846% |